1. Scientific Societies

1.1. General Clinical Pharmacology

  • SFPT - Société Française de Pharmacologie et de Thérapeutique 
  • AGAH - Arbeitsgemeinschaft für Angewandte Humanpharmakologie - Association for Applied Human Pharmacology
  • BPS - British Pharmacological Society
  • EACPT - European Association for Clinical Pharmacology and Therapeutics
  • ACCP - American College of Clinical Pharmacology 
  • ASCPT - American Society for Clinical Pharmacology and Therapeutics
  • AAPS  American Association of Pharmaceutical Scientists
  • ASoP - American Society of Pharmacometrics
  • PAGE - Population Approach Group Europe

1.2. Specific Areas and Therapeutics

  • ACNP - American College of Neuro-Psychopharmacology
  • CINP - The International College of Neuro-Psychopharmacology
  • ECNP - European College of Neuro-Psychopharmacology
  • CPDD - The College on Problems of Drug Dependence
  • The Antibody Society
  • CTAD - Clinical Trials on Alzheimer Disease
  • EADC - European Alzheimer’s Disease Consortium
  • ADNI - Alzheimer’s Disease Neuroimaging Initiative
  • SNM - Society of Nuclear Medicine and Molecular Imaging

2. Public Organization

2.1. Regulatory Agencies

EMA European Medicines Agency
EMA/EPAR European Public Assessment Report

AFSSAPS (FR) Agence française de sécurité sanitaire des produits de santé
AFSSAPS - Essais Clinique
AFSSAPS – Essai Clinique de Phase I

BfARM (GE)
FAMHP (BE)

FDA (US)

HC-SC (Health Canada)
ICH
MEB (NL)

MHRA (UK)

MPA (SW)
PEI (GE)

2.2. Other Public Organizations

HAS (Haute Autorité de Santé)
OMS / WHO
DIA
(Drug Information Association)
AMIPS (Association des Médecins des Industries des Produits de Santé)

3. Other Website of Interest

© CLUB PHASE 1        separation Mentions légalesCréditsContact